L26/P-070 A meta-analysis of Advanced Sperm Selection Techniques for assisted reproduction
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.406 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Garg und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Study question To evaluate the effectiveness and safety of advanced sperm selection techniques on assisted reproductive technology outcomes. Summary answer Sperm selected by hyaluronic acid binding may have little or no effect on live birth or clinical pregnancy but may reduce miscarriage. What is known already Advanced sperm selection techniques are increasingly employed in assisted reproductive technologies (ART) and intracytoplasmic sperm injection (ICSI), and are thought to improve the chance that structurally intact and mature sperm are selected for fertilisation. Strategies include selection according to surface charge, sperm apoptosis; sperm birefringence; magnetic-activated cell sorting; ability to bind to hyaluronic acid; microfluidic selection; and sperm morphology under ultra-high magnification. There is limited data on their efficacy, and prior meta-analysis has shown questionable benefit. This is the first meta-analysis using the Trustworthiness in RAndomised Controlled Trials (TRACT) assessment to evaluate the efficacy of advanced sperm selection. Study design, size, duration We conducted a systematic search of electronic databases (CENTRAL via the Cochrane Register of Studies Online, MEDLINE and Embase) for relevant randomised controlled trials (RCTs) in February 2025. Due to increasing concerns regarding untrusworthy data, the Trustworthiness in RAndomised Controlled Trials (TRACT) assessment was carried out for all eligible studies. Risk ratios (RRs) were calculated with 95% confidence intervals (CIs). We evaluated the quality of the evidence using GRADE methods. Participants/materials, setting, methods We included RCTs comparing advanced sperm selection techniques versus standard in vitro fertilisation (IVF), ICSI, or another technique. We excluded studies on intracytoplasmic morphologically selected sperm injection (IMSI). Two authors independently assessed study eligibility, extracted data and performed risk of bias using Cochrane’s tool. Primary outcomes measured were live birth and miscarriage per patient randomly assigned. Secondary outcome measures included clinical pregnancy per patient randomly assigned, miscarriage per clinical pregnancy and foetal abnormality. Main results and the role of chance We included five RCTs (3752 women). We found HA-ICSI may result in no difference or a slight increase in live birth per woman randomly assigned (there was a 25% chance of live birth with ICSI versus 24 %-31% with HA-ICSI, RR 1.09, 95% CI 0.97 to 1.24, 1 RCT, 2772 patients, low-quality evidence). HA-ICSI may decrease miscarriage per woman randomly assigned (6% chance with ICSI versus 3%-5% chance with HA-ICSI, RR 0.59, 95% CI 0.44 to 0.80, 3327 women, 2 RCTs, I2 = 0%, moderate-quality evidence) and per clinical pregnancy (16% chance with ICSI compared to 7%-13% chance with HA-ICSI, RR 0.60, 95% CI 0.45 to 0.80, 1207 women, I2 = 0%,2 RCTs, moderate-quality evidence). Little or no difference was found on the impact of HA-ICSI versus ICSI on clinical pregnancy. Zeta sperm selection has an uncertain impact in live birth compared to ICSI (RR 2.48, 95% CI 1.34 to 4.56, 1 RCT, 203 women). The impact of HA-ICSI compared with SpermSlow and MFSS compared with ICSI is uncertain in terms of with live birth, miscarriage or pregnancy rates, with very low quality evidence. Limitations, reasons for caution The quality of evidence ranged from very low to moderate. The main limitations were performance bias, selection bias and attrition bias. There were a low numbers of participants in the studies included. Not all studies reported data outcomes on foetal abnormalities. Wider implications of the findings The evidence suggests that sperm selected by hyaluronic acid binding may have little effect on live birth or clinical pregnancy but may reduce miscarriage. We are uncertain of the effect of Zeta sperm selection on live birth, clinical pregnancy, and miscarriage due to very low quality of the evidence. Trial registration number Yes
Zitieren
APA
Garg, A., Nakhla, O., Steeper, M., Afsana, A., Lepine, S., McDowell, S., Kroon, B., Glyjovsky, D., Yazdani, A., & Lensen, S. (2026). L26/P-070 A meta-analysis of Advanced Sperm Selection Techniques for assisted reproduction. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.406
Vancouver
Garg A, Nakhla O, Steeper M, Afsana A, Lepine S, McDowell S, et al. L26/P-070 A meta-analysis of Advanced Sperm Selection Techniques for assisted reproduction. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.406
BibTeX
@article{Garg2026,
author = {Garg, A. and Nakhla, O. and Steeper, M. and Afsana, A. and Lepine, S. and McDowell, S. and Kroon, B. and Glyjovsky, D. and Yazdani, A. and Lensen, S.},
title = {L26/P-070 A meta-analysis of Advanced Sperm Selection Techniques for assisted reproduction},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.406}
}
EUVIMED